Actively Recruiting
Photobiomodulation Therapy in the Management of Chemotherapy-Induced Peripheral Neuropathy
Led by Jessa Hospital · Updated on 2023-03-30
172
Participants Needed
1
Research Sites
363 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to investigate the effectiveness of photobiomodulation therapy (PBM) in the management of chemotherapy-induced peripheral neuropathy (CIPN). Therefore, the hypothesis is that PBM can reduce the severity of CIPN in cancer patients, increasing the patient's quality of life.
CONDITIONS
Official Title
Photobiomodulation Therapy in the Management of Chemotherapy-Induced Peripheral Neuropathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Finished chemotherapy with paclitaxel, docetaxel, oxaliplatin, cisplatin, vincristine, thalidomide, and/or bortezomib
- Diagnosed with chemotherapy-induced peripheral neuropathy (CIPN)
- Aged 18 years or older
- No documented or observable psychiatric or neurological disorders that could interfere with study participation (e.g., dementia or psychosis)
- Dutch-speaking
- Signed informed consent
You will not qualify if you...
- Taking stable doses of prescription medication for peripheral neuropathy, including gabapentin, pregabalin (Lyrica), nortriptyline, amitriptyline, duloxetine (Cymbalta), or venlafaxine
- Severe or unstable cardio-respiratory or musculoskeletal disease
- Interruption of more than two consecutive laser treatments
- Dark brown or black skin pigmentation (skin type VI on the Fitzpatrick scale)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Jessa Hospital
Hasselt, Limburg, Belgium, 3500
Actively Recruiting
Research Team
J
Jeroen Mebis, Prof. Dr.
CONTACT
M
Marithé Claes, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here